Reversal by L-DOPA of the suppression of locomotor activity induced by inhibition of tyrosine-hydroxylase and DA-beta-hydroxylase in mice.
D000818:Animals; D001921:Brain / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D002230:Carbidopa / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D004220:Disulfides / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D004299:Dopamine beta-Hydroxylase / Q000037:antagonists & inhibitors*; D005260:Female; D007093:Imidazoles / Q000494:pharmacology*; D008124:Locomotion / Q000187:drug effects*; D008781:Methyltyrosines / Q000494:pharmacology; D051379:Mice; D009638:Norepinephrine / Q000378:metabolism; D012110:Reserpine / Q000494:pharmacology; D009435:Synaptic Transmission / Q000187:drug effects; D014316:Tritium; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors*
D004220:Disulfides; D007093:Imidazoles; D008781:Methyltyrosines; D014316:Tritium; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D014446:Tyrosine 3-Monooxygenase; D004299:Dopamine beta-Hydroxylase; D002230:Carbidopa; D004298:Dopamine; D009638:Norepinephrine